stemcellreference | stemcellreference

Insurers In Japan Will Soon Offer Coverage to Cell-Cultivating Companies (Live Insurance News)

Posted in: News for Doctors, News for Industry, News for Patients | September 17, 2014 at 9:09 pm , by stemcellreference

No comments

(Tokyo, Japan) The non-life insurance companies in Japan will begin to sell policies to cover the cultivation of stem cells for regenerative medicine procedures....

Accurexa Announces License For UCSF Brain Stem Cell Device (Bay Street)

Posted in: News for Industry, News for Researchers | September 17, 2014 at 4:30 pm , by stemcellreference

No comments

(San Francisco, CA) The University of California, San Francisco announced that it has entered into an exclusive license agreement with Accurexa, Inc for global licensing of a medical stereotactic...

BioTime’s Cell Cure Neurosciences Ltd. Demonstrates Safety and Efficacy of OpRegen® in Animal Studies (Market Watch)

Posted in: News for Industry | September 17, 2014 at 4:23 pm , by stemcellreference

No comments

(Alameda, CA) BioTime Inc. completed a series of extensive preclinical safety and efficacy studies for its product OpRegen intended for treatment of dry age-related macular degeneration....

Quebec Leukemia Patient Mai Duong Finds Cord Blood Donor (CTV News)

Posted in: News for Doctors, News for Patients | September 17, 2014 at 4:06 pm , by stemcellreference

No comments

(Quebec, Canada) A patient has finally found a proper match for umbilical cord stem cells to treat her acute leukemia....

New Stem Cell Bio Drug for Bone Regeneration To Be Released in January (Miami Today News)

Posted in: News for Doctors, News for Industry, News for Patients | September 17, 2014 at 3:53 pm , by stemcellreference

No comments

(Miami, FL) An adult bone marrow isolated multi-lineage inducible cell called the Miami cell....

Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market (CNN)

Posted in: News for Industry | September 17, 2014 at 3:10 pm , by stemcellreference

No comments

(Haifa, Israel) Pluristem Therapeutics Inc. a leading developer of placenta-based cell therapy products is evaluating strategic opportunities to co-develop and commercialize cell therapy products in Japan....

Initial Six Teams to Compete for New Organ Liver Prize (PR Web)

Posted in: News for Doctors, News for Researchers | September 16, 2014 at 4:12 pm , by stemcellreference

No comments

(Washington, DC) Global competition with a $1 million prize for the first team to create a bioengineered solution to survive without native liver function....

Scientists Create Therapy-Grade Stem Cells Using New Cocktail to Reprogram Adult Cells (Phys)

Posted in: News for Industry, News for Researchers | September 16, 2014 at 3:04 pm , by stemcellreference

No comments

(Jerusalem, Israel) Researchers at the Hebrew University of Jerusalem have developed a new formulation that is highly effective in transforming adult stem cells into quality pluripotent stem cells....

Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% Annually (BCC Research)

Posted in: News for Industry | September 16, 2014 at 3:01 pm , by stemcellreference

No comments

(Wellesley, MA) BCC research reveals that the global market for stem cells is expected to grow to nearly $10.6 billion by the year 2018....

Researchers Discover What Lies Behind the Death of Stem Cells (Imperial)

Posted in: News for Researchers | September 16, 2014 at 2:59 pm , by stemcellreference

No comments

(London, England) Researchers identify small molecules called microRNA that play a key role in controlling the death and survival of pluripotent stem cells....